University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors

Phase 4

Conditions: Organ Transplantation

Interventions: Drug: EC-MPS
Drug: MMF

First Posted Date: 2008-02-11

Last Posted Date: 2009-02-17

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 400

Registration Number: NCT00611494

Locations: 🇨🇦
Toronto General Hospital - Multi Organ Transplant Program, Toronto, Ontario, Canada

Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone

Phase 1

Completed

Conditions: Renal Cell Carcinoma

Interventions: Drug: Sorafenib
Radiation: external beam radiotherapy

First Posted Date: 2008-02-07

Last Posted Date: 2015-07-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 12

Registration Number: NCT00609934

Locations: 🇨🇦
Princess Margaret Hosptial, Toronto, Ontario, Canada

A Study of Radiation With Sorafenib in Advanced Cancer

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: Sorafenib

First Posted Date: 2008-02-07

Last Posted Date: 2019-02-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 34

Registration Number: NCT00610246

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy

Completed

Conditions: Chronic Hepatitis C Virus Infection

Interventions: Other: No intervention

First Posted Date: 2008-02-04

Last Posted Date: 2013-07-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 54

Registration Number: NCT00606528

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Combined Resection of Colorectal Metastases

Phase 2

Completed

Conditions: Colorectal Cancer

First Posted Date: 2008-02-04

Last Posted Date: 2014-01-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 56

Registration Number: NCT00606398

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors

Phase 2

Completed

Conditions: Neuroendocrine Tumors

Interventions: Drug: Sorafenib
Drug: Cyclophosphamide

First Posted Date: 2008-01-31

Last Posted Date: 2019-02-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 22

Registration Number: NCT00605566

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

Phase 2

Completed

Conditions: Nasopharyngeal Cancer

Interventions: Drug: Gemcitabine
Drug: Carboplatin/Cisplatin
Drug: erlotinib

First Posted Date: 2008-01-29

Last Posted Date: 2019-02-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT00603915

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Hippocampal Radiation Exposure and Memory

Completed

Conditions: Trigeminal Neuralgia
Arteriovenous Malformation
Schwannoma

First Posted Date: 2008-01-29

Last Posted Date: 2016-06-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1

Registration Number: NCT00603694

Locations: 🇨🇦
Joey & Toby Tanenbaum Gamma Knife Centre, Toronto Western Hospital, Toronto, Ontario, Canada

Exploring the Role of 3T MRI in Gamma Knife Radiosurgery

Completed

Conditions: Brain Metastases

First Posted Date: 2008-01-28

Last Posted Date: 2016-06-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 45

Registration Number: NCT00602992

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

Phase 2

Terminated

Conditions: Prostatic Neoplasms
Fatigue

Interventions: Drug: Matched Placebo
Drug: Methylphenidate Hydrochloride

First Posted Date: 2008-01-15

Last Posted Date: 2014-06-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 33

Registration Number: NCT00593853

Locations: 🇨🇦
UHN Princess Margaret Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy